How many institutions held DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value in Q3 2022?

224 institutional investors reported DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value for Q3 2022. Use the holders table for investor-level position and value details.

DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX)

Q: What does CUSIP 268158201 represent in this 13F holders report?

CUSIP 268158201 is the security identifier for DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 268158201

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 117,273,296
Total 13F shares: 115,309,089
Share change: -2,465,536
Total reported value: $1,204,814,640
Put/Call ratio: 178%
Price per share: $10.44
Number of holders: 224
Value change: -$26,221,770
Number of buys: 110
Number of sells: 87

Quarterly Holders Quick Answers

What is CUSIP 268158201?
CUSIP 268158201 identifies DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 268158201:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q3 2022

As of 30 Sep 2022, DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) was held by 224 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 115,309,089 shares. The largest 10 holders included BlackRock Inc., FEDERATED HERMES, INC., STATE STREET CORP, VANGUARD GROUP INC, Chicago Capital, LLC, Bain Capital Life Sciences Investors, LLC, Fisher Asset Management, LLC, PFM Health Sciences, LP, BLAIR WILLIAM & CO/IL, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 225 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

201

Q3 2022 holders

224

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.